Press Releases
Mar. 8, 2026
Pulsenics joins Canadian trade mission to South Korea and Japan
Neutral
EIN Presswire
Mar. 6, 2026
Tokyo Gov. Tours Europe: Promoting Multicity Action at OECD in Paris, Friendship with Rome
Neutral
EIN Presswire
Mar. 3, 2026
Japan Sees Increase in Unemployment Rate
Indeterminate
MENAFN
Owner: Sawsan Dababneh
10 hours ago
Digital Biomarkers Market Growth Accelerates at 22.1% CAGR Through 2033 | Persistence Market Research
Neutral
EIN Presswire
Mar. 5, 2026
2026 International Conference on Young Women’s Breast Cancer and Health, November 14–15, Tokyo, Japan
Neutral
EIN Presswire
Mar. 5, 2026
Coenzyme Q10 Market to Reach $1,640M by 2032 from $789M in 2025, Boosted by Heart Health
Neutral
EIN Presswire
Mar. 2, 2026
Tokyo Lifestyle’s Hong Kong Subsidiary Enters into US$0.96 Million Loan Agreement with Principal Executive Officer
Indeterminate
GlobeNewswire, Inc.
Mar. 4, 2026
Nxera Pharma Submits Marketing Authorization Application for Daridorexant in South Korea
Indeterminate
GlobeNewswire, Inc.
Mar. 3, 2026
Deputy Minister Nomalungelo Gina: Japan’s National Day reception
Gov't Institution
South African Government
Owner: South African Government
Mar. 3, 2026
Resmed’s Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach
Indeterminate
GlobeNewswire, Inc.
Mar. 9, 2026
Dysmenorrhea Treatment Market Expands from US$7.2 Bn to US$12.7 Bn | Persistence Market Research
Neutral
EIN Presswire
11 hours ago
Testosterone Booster Market Size to Hit US$568.0 Mn by 2033 | Persistence Market Research
Neutral
EIN Presswire
Mar. 2, 2026
Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing
Indeterminate
GlobeNewswire, Inc.
Mar. 2, 2026
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing
Indeterminate
GlobeNewswire, Inc.
Mar. 2, 2026
Press Release: Sanofi’s rilzabrutinib earns orphan drug designation in Japan for IgG4-related disease
Indeterminate
GlobeNewswire, Inc.